» Articles » PMID: 15326355

Enhanced Dendritic Cell Antigen Capture Via Toll-like Receptor-induced Actin Remodeling

Overview
Journal Science
Specialty Science
Date 2004 Aug 25
PMID 15326355
Citations 214
Authors
Affiliations
Soon will be listed here.
Abstract

Microbial products are sensed through Toll-like receptors (TLRs) and trigger a program of dendritic cell (DC) maturation that enables DCs to activate T cells. Although an accepted hallmark of this response is eventual down-regulation of DC endocytic capacity, we show that TLR ligands first acutely stimulate antigen macropinocytosis, leading to enhanced presentation on class I and class II major histocompatibility complex molecules. Simultaneously, actin-rich podosomes disappear, which suggests a coordinated redeployment of actin to fuel endocytosis. These reciprocal changes are transient and require p38 and extracellular signal-regulated kinase activation. Thus, the DC actin cytoskeleton can be rapidly mobilized in response to innate immune stimuli to enhance antigen capture and presentation.

Citing Articles

Iterative selection of lipid nanoparticle vaccine adjuvants for rapid elicitation of tumoricidal CD8⁺ T cells.

Luo Y, Zhou S, Song Y, Huang W, Wilding G, Jablonski J Bioact Mater. 2025; 48:189-199.

PMID: 40046011 PMC: 11880734. DOI: 10.1016/j.bioactmat.2025.01.028.


The effect of microbial metabolites from colonic protein fermentation on bacteria-induced cytokine production in dendritic cells.

Xie Z, Eriksen D, Johnsen P, Nielsen D, Frokiaer H Biofactors. 2025; 51(1):e70007.

PMID: 39992073 PMC: 11849446. DOI: 10.1002/biof.70007.


Targeted protein degradation: advances in drug discovery and clinical practice.

Zhong G, Chang X, Xie W, Zhou X Signal Transduct Target Ther. 2024; 9(1):308.

PMID: 39500878 PMC: 11539257. DOI: 10.1038/s41392-024-02004-x.


Flagellate bacteria-mediated tumour antigen delivery: A novel approach to enhance dendritic cell activation for in situ cancer vaccination.

Xia W, Wu J Microb Biotechnol. 2024; 17(10):e70028.

PMID: 39422491 PMC: 11487680. DOI: 10.1111/1751-7915.70028.


Vaccine approaches to treat urothelial cancer.

Giudice G, Sonpavde G Hum Vaccin Immunother. 2024; 20(1):2379086.

PMID: 39043175 PMC: 11268260. DOI: 10.1080/21645515.2024.2379086.